VP
venBio Partners Portfolio holdings
AUM
$115M
This Quarter Return
-12.92%
1 Year Return
-33.99%
3 Year Return
+221.07%
5 Year Return
+224.54%
10 Year Return
–
AUM
$451M
AUM Growth
+$451M
(-19%)
Cap. Flow
-$23.4M
Cap. Flow
% of AUM
-5.2%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$34.7M |
Top Sells
| 1 |
Harmony Biosciences
HRMY
|
$58.2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
ALX Oncology
ALXO
$62.7M
| $164M | 36.34% | 9,699,925 | – | – |
|
|
2
Harmony Biosciences
HRMY
$2.12B
| $75.1M | 16.66% | 1,544,484 -1,195,927 | -44% | -$58.2M |
|
3
Ventyx Biosciences
VTYX
$171M
| $68M | 15.08% | 5,011,536 | – | – |
|
4
Pharvaris
PHVS
$1.39B
| $41.8M | 9.26% | 2,303,310 | – | – |
|
|
CINC
5
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $34.7M | 7.7% | +1,980,706 | New | +$34.7M |
|
6
Akero Therapeutics
AKRO
$3.74B
| $30.8M | 6.83% | 2,171,664 | – | – |
|
|
IMPL
7
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $17.6M | 3.9% | 2,759,791 | – | – |
|
|
CMPI
8
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
| $11.7M | 2.6% | 3,673,374 | – | – |
|
|
ELEV
9
DELISTED
Elevation Oncology
ELEV
| $6.57M | 1.46% | 2,608,167 | – | – |
|
|
VRNA
10
Verona Pharma
VRNA
$9.16B
| $808K | 0.18% | 161,897 | – | – |
|